beta-D-Galp-(1->3)-D-GlcpN → D-Galactosamine

HRID 1585189

반응식

HRID 1585189 반응식
[O:1]([C@H:13]1[C@H:19]([OH:20])[C@@H:18]([CH2:21][OH:22])[O:17][CH:15]([OH:16])[C@@H:14]1[NH2:23])[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O.[O:24]([C@H:36]1[C@@H:42]([OH:43])[C@@H:41]([CH2:44][OH:45])[O:40][CH:38]([OH:39])[C@@H:37]1[NH2:46])[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O>>[OH:16][CH:15]1[O:17][C@H:18]([CH2:21][OH:22])[C@@H:19]([OH:20])[C@H:13]([OH:1])[C@H:14]1[NH2:23].[OH:39][CH:38]1[O:40][C@H:41]([CH2:44][OH:45])[C@H:42]([OH:43])[C@H:36]([OH:24])[C@H:37]1[NH2:46]

참가 물질

4

실험 절차

Synthesis of Galβ1-3GlcNH2 βSEt and Galβ1-3GalNH2 βSEt. See example 1, similar conditions and enzyme may be used, but instead GlcNH2 βSEt, or GalNH2 βSEt to obtain the latter product, is used as the acceptor. Here, extraction is less favorable for isolation, and instead ion-exchanger as above may be used followed by e.g. precipitation or a second chromatographic step.

출처 및 근거

ORD 기록
ord-a5ab09a504e049068eafe2b223197765
출처 데이터셋
uspto-grants-1999_08
특허 번호
US05936075

연결된 노트

불러오는 중…